Aadi Bioscience, Inc.
Clinical trials sponsored by Aadi Bioscience, Inc., explained in plain language.
-
New hope for cancer patients with liver issues: drug safety trial launches
Disease control Recruiting nowThis early-stage study tests a drug called nab-sirolimus in people with advanced solid tumors who also have moderate liver impairment. The goal is to find a safe dose and see how the body processes the drug. About 28 adults will take part, and the study is currently recruiting.
Phase: PHASE1 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated May 17, 2026 08:53 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis study tests a combination of two drugs, nab-sirolimus and letrozole, in people with advanced or recurrent endometrioid endometrial cancer. The goal is to see if the combination can shrink or control tumors. About 29 participants will receive the treatment, and researchers wi…
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC